Niki BioSolutions, Inc. (NIKI) Total liabilities 2023–2025
Niki BioSolutions, Inc. (NIKI) total liabilities at each fiscal year-end, per SEC filings.
$5.3MFY2025 · since FY2023: $4.4M → $5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.3M | -59.7% |
| FY2024 | $13.0M | +196.2% |
| FY2023 | $4.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net incomeNIKI Net marginNIKI Gross profitNIKI Gross marginNIKI Operating incomeNIKI Operating marginNIKI Operating cash flowNIKI Free cash flowNIKI Capital expendituresNIKI Return on equityNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Shareholders’ equityNIKI overview →